Cachexia Global Clinical Trials Review, H1, 2015
Summary
GlobalData's clinical trial report, “Cachexia Global Clinical Trials Review, H1, 2015" provides an overview of Cachexia clinical trials scenario. This report provides top line data relating to the clinical trials on Cachexia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Datas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cachexia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cachexia to Musculoskeletal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cachexia to Musculoskeletal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Cachexia 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Cachexia Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Cachexia 33
May 20, 2015: Helsinn Group to present data on Anamorelin at 2015 ASCO 33
Apr 20, 2015: AVEO Oncology Announces Presentation of AV-380 Preclinical Data in Cancer Associated Cachexia at 2015 Annual Meeting of the American Association of Cancer Research 33
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Pfizer Inc. 35
Clinical Trial Overview of Pfizer Inc. 35
Helsinn Healthcare S.A. (Inactive) 36
Clinical Trial Overview of Helsinn Healthcare S.A. (Inactive) 36
GlaxoSmithKline Plc 37
Clinical Trial Overview of GlaxoSmithKline Plc 37
Novartis AG 38
Clinical Trial Overview of Novartis AG 38
Medpace, Inc. 39
Clinical Trial Overview of Medpace, Inc. 39
Helsinn Holding S.A. 40
Clinical Trial Overview of Helsinn Holding S.A. 40
Galapagos NV 41
Clinical Trial Overview of Galapagos NV 41
Bristol-Myers Squibb Company 42
Clinical Trial Overview of Bristol-Myers Squibb Company 42
Alder Biopharmaceuticals Inc. 43
Clinical Trial Overview of Alder Biopharmaceuticals Inc. 43
Aeterna Zentaris Inc. 44
Clinical Trial Overview of Aeterna Zentaris Inc. 44
Clinical Trial Overview of Top Institutes / Government 45
The National Institute of Allergy and Infectious Diseases 45
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 45
Asan Medical Center 46
Clinical Trial Overview of Asan Medical Center 46
Derby Hospitals NHS Foundation Trust 47
Clinical Trial Overview of Derby Hospitals NHS Foundation Trust 47
National Cancer Institute 48
Clinical Trial Overview of National Cancer Institute 48
North Central Cancer Treatment Group 50
Clinical Trial Overview of North Central Cancer Treatment Group 50
The National Institute of Diabetes and Digestive and Kidney Diseases 51
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 51
Wake Forest Baptist Medical Center 52
Clinical Trial Overview of Wake Forest Baptist Medical Center 52
Alberta Health Services 53
Clinical Trial Overview of Alberta Health Services 53
Baylor College of Medicine 54
Clinical Trial Overview of Baylor College of Medicine 54
Bruyere Continuing Care 55
Clinical Trial Overview of Bruyere Continuing Care 55
Five Key Clinical Profiles 56
Appendix 80
Abbreviations 80
Definitions 80
Research Methodology 81
Secondary Research 81
About GlobalData 82
Contact Us 82
Disclaimer 82
Source 83
List Of Tables
List of Tables
Cachexia Therapeutics, Global, Clinical Trials by Region, 2015* 7
Cachexia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Cachexia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Cachexia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Cachexia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Cachexia Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Cachexia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Cachexia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Cachexia to Musculoskeletal Clinical Trials, G7 Countries (%), 2015* 15
Cachexia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Cachexia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Cachexia to Musculoskeletal Clinical Trials, E7 Countries (%), 2015* 18
Cachexia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Cachexia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Cachexia Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Cachexia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Cachexia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Cachexia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Cachexia Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Cachexia Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Cachexia Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Cachexia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Cachexia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Cachexia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Cachexia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Cachexia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 35
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinn Healthcare S.A. (Inactive), 2015* 36
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 37
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 38
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medpace, Inc., 2015* 39
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinn Holding S.A., 2015* 40
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Galapagos NV, 2015* 41
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 42
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Alder Biopharmaceuticals Inc., 2015* 43
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aeterna Zentaris Inc., 2015* 44
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 45
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015* 46
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Derby Hospitals NHS Foundation Trust, 2015* 47
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 48
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2015* 50
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 51
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest Baptist Medical Center, 2015* 52
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Health Services, 2015* 53
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015* 54
Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bruyere Continuing Care, 2015* 55
List Of Figures
Cachexia Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Cachexia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Cachexia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Cachexia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Cachexia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Cachexia Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Cachexia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Cachexia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Cachexia to Musculoskeletal Clinical Trials, G7 Countries (%), 2015* 15
Cachexia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Cachexia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Cachexia to Musculoskeletal Clinical Trials, E7 Countries (%), 2015* 18
Cachexia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Cachexia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Cachexia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Cachexia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Cachexia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Cachexia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Cachexia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Cachexia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Cachexia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Cachexia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Cachexia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 81
